Daily programme - Thursday 15 November 2012

Title of symposia	Section(s)	Coordinators
Thursday, 15 November 2012: 08:00 - 10:00
1. TB REACH: results from TB case finding innovations in the first two Waves	TB	Jacob Creswell (Switzerland)
2. Pharmacists can help protect TB drugs and do more to sustain TB control: how can TB programmes engage them?	TB/NAPs	Mukund Uplekar (Switzerland), Monica Dias-yesudian (Switzerland)
3. Progress and prospects: sustainability of TB vaccine development	TB	Jennifer Woolley (USA)
4. Challenges in the design and conduct of clinical trials for improving the treatment of tuberculosis	TB	Patrick Phillips (UK)
5. Capitalising corporate sector strengths to address TB and HIV challenges	HIV	Monica Dias-Yesudian (Switzerland)
6. Ensuring the quality of TB laboratory services	TB/Bact.	Thomas Shinnick (USA), Christopher Gilpin (Switzerland)
7. Who has the right to health care and who is responsible for ensuring it?	LH/TB	Mary E. Edginton (South Africa)
8. The role of communications in changing social norms and promoting public health policy in LMICs	TC	Rebecca Perl (USA), Alexey Kotov (USA)
9. WHO guidelines on screening for active tuberculosis	TB	Knut Lonnroth (Switzerland), Elisabeth Corbett (Malawi)
Thursday, 15 November 2012: 14:30 - 16:30
10. Rolling out XpertMTB/RIF: bringing donors, laboratories and programmes together for sustainability	HIV/TB	Bess Miller (USA), Heather Alexander (USA)
11. Translating TB projects into sustainable TB programmes: lessons from the WHO-CIDA initiative	TB	Monica Dias-Yesudian (Switzerland), Mukund Uplekar (Switzerland)
12. Tuberculosis screening programmes for healthy migration and strengthening tuberculosis control programmes	TB	Deliana Garcia (USA), Drew Posey (USA)
13. Challenges and solutions for sustainable TB and TB-HIV care among migrants and marginalised populations	TB/NAPs	Trini Mathew (USA), Poonam Dhavan (Philippines)
14. Building national and international partnerships to ensure a sustainable response to TB challenges	TB	Elisabetta Minelli (Switzerland), Mandy Slutsker (USA)
15. A realistic assessment of programmatic management of DR-TB (PMDT) scale-up achievements, challenges and opportunities	TB	Catharina Van Weezenbeek (Philippines), Michael Rich (USA)
16. Effective aid for better lung health: good practices on sustainability and mutual responsibility	TB/LH	Patrick Bertrand (France)
17. Monitoring the global tobacco epidemic: strategic and sustainable system	TC	Yang Song (USA), Susan Mercado (Philippines)
18. Tuberculosis in prisons: breaking the cycle through integration with community health services	TB	Philipp Du Cros (UK), Sarabjit Chadha (India)

abstract sessions

POSTER DISCUSSION SESSIONS

Click here to download the full poster discussion sessions list as one PDF file.

Abstract poster discussion session	Section	Time
Thursday 15 November 2012
01. TB diagnostics: culture and rapid detection - I	Bacteriology	10:15 - 11:15
02. TB laboratory network: management of EQA	Bacteriology	10:15 - 11:15
03. Molecular genetic and other rapid drug susceptibility testing	Bacteriology	10:15 - 11:15
04. B.R.I.C. and beyond: special populations in emerging and high income countries	Tuberculosis	10:15 - 11:15
05. Tobacco cessation	Tobacco control	10:15 - 11:15
06. Epidemiology: TB in high and low burden countries - I	Tuberculosis	10:15 - 11:15
07. Training and knowledge assessment	NAPs	10:15 - 11:15
08. Medical management of TB - I	Tuberculosis	10:15 - 11:15
09. Public-policy - I	Tuberculosis	10:15 - 11:15
10. TB-HIV pharmacology and clinical issues	HIV	10:15 - 11:15
11. Expansion of the Stop TB strategy - I	Tuberculosis	10:15 - 11:15
12. Improving TB surveillance in children	Lung Health	10:15 - 11:15
13. Tobacco burden and surveillance	Tobacco control	10:15 - 11:15
14. MDR-TB: civil society, costs, counselling and case fatality	Tuberculosis	10:15 - 11:15
15. MDR-TB: treatment outcomes	Tuberculosis	10:15 - 11:15
16. MDR-TB: focus on surveillance	Tuberculosis	10:15 - 11:15
17. TB management: food security and community issues	Tuberculosis	10:15 - 11:15
18. TB management: innovations in communication	Tuberculosis	10:15 - 11:15

ORAL ABSTRACT SESSIONS

Click here to download the full oral abstract sessions list as one PDF file.

Oral Abstract Session	Time	Section
Thursday, 15 November 2012
01. Modern molecular technologies in TB diagnosis	12:45-14:15	Bacteriology
02. HIV testing and TB screening: the complete package	12:45-14:15	HIV
03. Preventive therapy, populations and pharmacokinetics: special issues in TB-HIV	12:45-14:15	HIV
04. Pneumonia in adults and children: preventing deaths	12:45-14:15	Lung Health
05. Money, meetings and training: best practices to improve TB care	12:45-14:15	Nurses and Allied Professionals
06. Mothers, Migrants, Military and More: TB in special populations	12:45-14:15	Tuberculosis

plenary sessions

Speaker: Guy Marks (Australia) - Consultant physician at Liverpool Hospital in Sydney, Australia and Editor-in-Chief (Lung Diseases) of the International Journal of Tuberculosis and Lung Disease.

Time: 11:30 - 12:30

Room: Plenary Hall

Plenary session 1:

"Global burden of respiratory disease"

Guy_Marks_600x800

Click here for full details on the Plenary session 1.

the sponsored satellite symposia programme

Please click here to download the full list of Sponsored Satellite Symposia as one PDF file.

Title of Sponsored Satellite Symposia	Organised by	Room
Thursday, 15 November 2012: 17:00 - 18:30
01. Making markets work for tuberculosis: fostering a healthy micromarket for paediatric TB medicines through innovative market approaches	UNITAID	Plenary Theatre
02. Virtual implementation (modelling) as a practical tool to evaluate new TB diagnostics	TREAT TB	Conference Hall 1
03. Systems approach for tobacco control in India: a comprehensive tobacco control model for scale-up	Public Health Foundation of India	Conference Hall 3
04. The double burden of tuberculosis and diabetes: evidence and collaborative efforts	World Diabetes Foundation	304/305

union scientific working group meetings

Open to all delegates

The Union currently has 15 working groups that undertake specific projects within fixed time-frames. Activities undertaken by current groups include developing official policy statements, publishing technical guides and other resources, carrying out research projects, raising global awareness of topical TB and lung health issues and providing a forum for discussion and development. Self-funded, working groups rely on the support and dynamism of members in order to flourish and achieve their aims. Non-Union members are welcome to attend the working group meetings and find out more about projects and plans for 2013, as well as how to become involved.

Thursday, 15 November 2012
10:15 - 11:15	TB Infection control	Room: Conference Hall 3
10:15 - 11:15	TB social determinants and ethics	Room: Conference Hall 1
10:15 - 11:15	Strengthening NCD prevention through tobacco control	Room: 306
10:15 - 11:15	Best practice for patient care	Room: 307
10:15 - 11:15	COPD in low- and middle-income countries	Room:310
12:45 - 13:45	TB and migration	Room: 304/305
12:45 - 13:45	Countering tobacco industry interference in public health policies	Room: 306
12:45 - 13:45	Global Indigenous Stop TB Initiative	Room: 401/402
12:45 - 13:45	Regional mobilisation of Nurses and Allied Professionals	Room: 307
12:45 - 13:45	Child TB training tools	Room: 310
16:45 - 17:45	TB control in Prisons	Room: Conference Hall 2
16:45 - 17:45	Getting research into Tobacco Control policy at regional and country level	Room: 306
16:45 - 17:45	TB laboratory accreditation	Room: 401/402
16:45 - 17:45	TB education and training	Room: 307
16:45 - 17:45	Tobacco cessation interventions for tuberculosis patients	Room: 310

side meetings

Annual Resist-TB meeting

Thursday, 15 November 2012

_____________________________________________________

10:15-11: 15: Room: 304/305

(Meeting open to all delegates)

This meeting is open to all and should be attended by anyone interested in learning about clinical trials to improve the treatment of patients with MDR-TB. Sessions will cover 1) Clinical trials of MDR-TB currently underway; 2) Clinical trials for MDR-TB in the planning stage; and 3) Availability of new drugs for patients with MDR and XDR-TB through Compassionate Use and Expanded Access Programs.

Coordinator: Nadza Durakovic (USA) Chair: C. Robert Horsburgh Jr, Boston University School of Public Health (USA)